Physician profile
David Defeo
NPI 1003851395
$6,000.54
in general payments reported to CMS, 2019-2025
54 companies · $1,404 in 2025
The $1,404 reported for 2025 was more than what 82% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2020: $290 · 2021: $724 · 2022: $814 · 2023: $1,145 · 2024: $1,081 · 2025: $1,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,612 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,612.48 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $738.45 | 2019-2025 | Breztri, Airsupra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $651.79 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Glaxosmithkline, LLC. | $651.42 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Mallinckrodt Hospital Products INC. | $338.94 | 2020-2025 | Acthar |
| Grifols USA, LLC | $319.04 | 2019-2025 | Prolastin-C Liquid, Xembify |
| United Therapeutics Corporation | $315.58 | 2022-2025 | Tyvaso, Tyvaso |
| Gilead Sciences, INC. | $255.43 | 2020-2024 | Veklury |
| Regeneron Healthcare Solutions, INC. | $221.16 | 2019-2025 | Dupixent |
| Inspire Medical Systems, INC. | $203.62 | 2025 | Inspire |
| Genzyme Corporation | $187.35 | 2019-2025 | |
| Insmed, INC. | $159.39 | 2020-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $156.69 | 2019-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $136.09 | 2021-2025 | Glassia, Hyqvia |
| Merck Sharp & Dohme LLC | $134.19 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Actelion Pharmaceuticals US, INC. | $111.61 | 2019-2024 | Opsumit, Uptravi |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $100.37 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Zoll Respicardia, INC. | $85.40 | 2024 | Remede System |
| Viatris Specialty LLC | $79.22 | 2025 | Yupelri |
| Pfizer INC. | $79.18 | 2019-2025 | |
| Baxter Healthcare | $78.32 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Inogen, INC. | $75.82 | 2023-2024 | Inogen |
| Novartis Pharmaceuticals Corporation | $63.33 | 2022-2023 | |
| Vifor Pharma, INC. | $61.36 | 2024 | Veltassa, Zemaira |
| Shionogi INC | $57.38 | 2021-2023 | Fetroja |
| Avadel Cns Pharmaceuticals, LLC | $56.01 | 2024-2025 | Lumryz |
| Amgen INC. | $50.09 | 2024-2025 | Tezspire, Tavneos |
| Electromed, INC. | $43.22 | 2019-2024 | Smartvest |
| Verona Pharma, INC. | $40.45 | 2025 | Ohtuvayre |
| Genentech USA, INC. | $39.10 | 2019 | |
| Advanced Respiratory, INC | $38.38 | 2020-2021 | |
| Covis Pharma Gmbh | $38.21 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $36.20 | 2022 | |
| Abiomed | $35.62 | 2020-2023 | Impella |
| La Jolla Pharmaceutical Company | $33.09 | 2021-2023 | Giapreza |
| Hospira, INC. | $30.17 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $29.60 | 2021 | |
| Paratek Pharmaceuticals, INC. | $26.78 | 2021-2022 | |
| Csl Behring | $24.76 | 2024 | Hizentra |
| Tempus Ai, INC | $22.69 | 2025 | Xt Cdx |
| 3b Medical, INC. | $19.20 | 2025 | Luna |
| Bio Products Laboratory USA, INC. | $18.17 | 2019 | |
| Axsome Therapeutics, INC. | $17.88 | 2022 | |
| Tactile Systems Technology INC | $17.80 | 2021 | |
| Lilly USA, LLC | $16.93 | 2024 | Mounjaro |
| Mallinckrodt Enterprises LLC | $16.08 | 2019 | |
| Sanofi Pasteur INC. | $14.05 | 2022 | |
| Allergan, INC. | $13.32 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.12 | 2019 | |
| Sunovion Pharmaceuticals INC. | $12.72 | 2020 | |
| Alexion Pharmaceuticals, INC. | $12.71 | 2020 | |
| Phadia US INC. | $11.86 | 2022 | |
| Portola Pharmaceuticals, LLC | $11.20 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Defeo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.